These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16734954)

  • 1. Nevirapine toxicity.
    Taiwo BO
    Int J STD AIDS; 2006 Jun; 17(6):364-9; quiz 370. PubMed ID: 16734954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk for immune-mediated liver reactions by nevirapine revisited.
    Medrano J; Barreiro P; Tuma P; Vispo E; Labarga P; Blanco F; Soriano V
    AIDS Rev; 2008; 10(2):110-5. PubMed ID: 18615121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals.
    Patel SM; Johnson S; Belknap SM; Chan J; Sha BE; Bennett C
    J Acquir Immune Defic Syndr; 2004 Feb; 35(2):120-5. PubMed ID: 14722442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third-trimester maternal toxicity with nevirapine use in pregnancy.
    Joy S; Poi M; Hughes L; Brady MT; Koletar SL; Para MF; Fan-Havard P
    Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1032-8. PubMed ID: 16260522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine toxicity in a cohort of HIV-1-infected pregnant women.
    João EC; Calvet GA; Menezes JA; D'Ippolito MM; Cruz ML; Salgado LA; Matos HJ
    Am J Obstet Gynecol; 2006 Jan; 194(1):199-202. PubMed ID: 16389032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA advisory on nevirapine.
    AIDS Treat News; 2005 Jan; (409):7. PubMed ID: 15791716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women.
    Phanuphak N; Apornpong T; Teeratakulpisarn S; Chaithongwongwatthana S; Taweepolcharoen C; Mangclaviraj S; Limpongsanurak S; Jadwattanakul T; Eiamapichart P; Luesomboon W; Apisarnthanarak A; Kamudhamas A; Tangsathapornpong A; Vitavasiri C; Singhakowinta N; Attakornwattana V; Kriengsinyot R; Methajittiphun P; Chunloy K; Preetiyathorn W; Aumchantr T; Toro P; Abrams EJ; El-Sadr W; Phanuphak P
    HIV Med; 2007 Sep; 8(6):357-66. PubMed ID: 17661843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virammune and women in the news.
    Emery C
    Surviv News (Atlanta Ga); 2005; 16(2):10. PubMed ID: 16158512
    [No Abstract]   [Full Text] [Related]  

  • 9. Serious toxicity associated with continuous nevirapine-based HAART in pregnancy.
    van Schalkwyk JE; Alimenti A; Khoo D; Maan E; Forbes JC; Burdge DR; Gilgoff S; Money DM
    BJOG; 2008 Sep; 115(10):1297-302. PubMed ID: 18715416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.
    Martinson NA; Morris L; Johnson J; Gray GE; Pillay V; Ledwaba J; Dhlamini P; Cohen S; Puren A; Steyn J; Heneine W; McIntyre JA
    AIDS; 2009 Apr; 23(7):809-16. PubMed ID: 19287298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
    Nightingale S; Dabis F
    J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674
    [No Abstract]   [Full Text] [Related]  

  • 12. Nevirapine-associated toxicity in clinical practice in Buenos Aires, Argentina.
    Bottaro EG; Huberman MJ; Iannella Mdel C; Vesperoni FA; Scapellato PG; Errea S; Antonelli L; Cassetti LI
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):306-12. PubMed ID: 20923955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments by Global Strategies for HIV Prevention on nevirapine resistance.
    GMHC Treat Issues; 2004; 18(11-12):15. PubMed ID: 15751140
    [No Abstract]   [Full Text] [Related]  

  • 14. Nevirapine (Viramune) strengthens warning on liver, skin toxicities.
    AIDS Treat News; 2000 Nov; (355):3-5. PubMed ID: 12170998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy at conception in pregnant women with HIV in Italy: wide range of variability and frequent exposure to contraindicated drugs.
    Floridia M; Tamburrini E; Ravizza M; Anzidei G; Tibaldi C; Bucceri A; Maccabruni A; Guaraldi G; Meloni A; Ravagni Probizer MF; Guerrao B; Martinelli P;
    Antivir Ther; 2006; 11(7):941-6. PubMed ID: 17302258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which ART regimen is best after receipt of single-dose nevirapine?
    Ryan CT
    AIDS Clin Care; 2009 Jan; 21(1):6. PubMed ID: 19230057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up survey of women who have undergone a prevention of mother-to-child transmission program in a resource-poor setting in South Africa.
    Peltzer K; Mosala T; Dana P; Fomundam H
    J Assoc Nurses AIDS Care; 2008; 19(6):450-60. PubMed ID: 19007723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.
    Westreich D; Eron J; Behets F; Horst Cv; Van Rie A
    J Infect Dis; 2007 Mar; 195(6):837-46. PubMed ID: 17299714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurses in Zambia gain access to antiretroviral treatment.
    Int Nurs Rev; 2004 Mar; 51(1):6. PubMed ID: 14764008
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance with short-course nevirapine.
    AIDS Patient Care STDS; 2005 Mar; 19(3):202. PubMed ID: 15844228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.